Synapse - Gregory Riely

Search Within

Gregory J Riely

Results (44)

5-day dosing schedule of temozolomide in relapsed sensitive or refractory small cell lung cancer (SCLC) and methyl-guanine-DNA methyltransferase (MGMT) analysis in a phase II trial

Meeting Abstract

Drilon, A. E. D. C.; Kyuichi, K.; Huberman, K. H.; Sima, C. S.; Fiore, J. J.; Yu, H. A.; Varghese, A. M.; Sumner, D. K.; Travis, W. D.; Heguy, A.; more...
Journal of Clinical Oncology (2012)

Fulltext@MSK | Save

Distinct clinical course of EGFR-mutant resected lung cancers: Results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib

Journal Article

D'Angelo, S. P.; Janjigian, Y. Y.; Ahye, N.; Riely, G. J.; Chaft, J. E.; Sima, C. S.; Shen, R.; Zheng, J.; Dycoco, J.; Kris, M. G.; more...
Journal of Thoracic Oncology (2012)

Fulltext@MSK | Save

HER2 amplification: A potential mechanism of acquired resistance to egfr inhibition in EGFR -mutant lung cancers that lack the second-site EGFR T790M mutation

Journal Article

Takezawa, K.; Pirazzoli, V.; Arcila, M. E.; Nebhan, C. A.; Song, X.; de Stanchina, E.; Ohashi, K.; Janjigian, Y. Y.; Spitzler, P. J.; Melnick, M. A.; more...
Cancer Discovery (2012)

Fulltext@MSK | Save

Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib

Journal Article

Oxnard, G. R.; Janjigian, Y. Y.; Arcila, M. E.; Sima, C. S.; Kass, S. L.; Riely, G. J.; Pao, W.; Kris, M. G.; Ladanyi, M.; Azzoli, C. G.; more...
Clinical Cancer Research (2011)

Fulltext@MSK | Save

Phase I/II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib

Journal Article

Janjigian, Y. Y.; Azzoli, C. G.; Krug, L. M.; Pereira, L. K.; Rizvi, N. A.; Pietanza, M. C.; Kris, M. G.; Ginsberg, M. S.; Pao, W.; Miller, V. A.; more...
Clinical Cancer Research (2011)

Fulltext@MSK | Save

Phase II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib

Meeting Abstract

Riely, G. J.; Janjigian, Y. Y.; Azzoli, C. G.; Pietanza, M.; Krug, L. M.; Rizvi, N. A.; Kris, M. G.; Miller, V. A.; Pao, W.; Ginsberg, M. S.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Prognostic implications of mutations in the epidermal growth factor receptor (EGFR) and KRAS among never-smokers with adenocarcinoma of the lung

Meeting Abstract

Paik, P. K.; Johnson, M. L.; D'Angelo, S. P.; Sima, C.; Janjigian, Y. Y.; Riely, G. J.; Kris, M. G.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinoma

Meeting Abstract

Johnson, M. L.; Sima, C.; Paik, P. K.; Janjigian, Y. Y.; Pao, W.; Kris, M. G.; Ladanyi, M.; Riely, G. J.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Impact of EGFR and KRAS mutations on survival in 1,000 patients with resected lung adenocarcinoma

Meeting Abstract

D'Angelo, S. P.; Janjigian, Y. Y.; Kris, M. G.; Pao, W.; Riely, G. J.; Marks, J.; Sima, C.; Dycoco, J.; Park, B. J.; Azzoli, C. G.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/ IV nonsmall cell lung cancer

Journal Article

Janjigian, Y. Y.; Mcdonnell, K.; Kris, M. G.; Shen, R.; Sima, C. S.; Bach, P. B.; Rizvi, N. A.; Riely, G. J.
Cancer (2010)

Fulltext@MSK | Save